Brooklyn Roasting Company's Cold Brew Recall Puts Botulism in the Spotlight
For a lot of guys, cold brew has become as essential to the morning routine as a razor and a clean shirt — something grabbed from the fridge, poured over ice, and counted on to perform. That trust, at least for customers of one well-regarded New York roaster, just took a serious hit. Brooklyn Roasting Company is in the middle of a federally escalated food recall involving its Pasteurized Cold Brew Concentrate, a product distributed across New York and New Jersey, and the reason for that recall — the potential growth of one of nature's most potent toxins — is not something to brush past without understanding what it actually means.
What Happened: The Recall in Full Detail
The recall was initiated on July 2 by the cold brew's manufacturer, Brooklyn Roasting Works, LLC, when it was found that the product had been improperly stored at room temperature. That single operational failure — a lapse in cold-chain management rather than a contamination event at the brewing stage — set off a chain of regulatory consequences that eventually drew the full attention of the U.S. Food and Drug Administration.
Brooklyn Roasting Company pulled 3,000 gallons of its Pasteurized Cold Brew Concentrate from shelves across New Jersey and New York, with the recall affecting 1,219 units of the company's 2.5-gallon boxed cold brew, which were distributed to stores between April 1 and June 20. The recall applies to the Pasteurized Cold Brew Concentrate with best-by dates from June 3 through September 3, according to the FDA. The format of the product — a bag-in-a-box design — is commonly used in foodservice and specialty retail, and the FDA notes that it was "bag in a box distributed" between April 1, 2026 and June 20, 2026.
On July 21, the FDA updated the recall to Class II status — the agency's second-highest level of alert. That escalation, three weeks after the company's initial voluntary action, signals that federal regulators took a hard look at the nature of the risk and decided the public needed to be formally notified at a higher tier. It was not a routine administrative update.
Where the Product Was Sold
Brooklyn Roasting Company sells its products through its own cafés, specialty coffee retailers, independent markets, gourmet grocery stores, and online. The company has not disclosed which specific stores received affected batches, so the burden falls on consumers to check the label themselves. That ambiguity is frustrating for anyone who bought a box through a third-party retailer or at a local café without keeping the original packaging. If the dates and distribution window match, the guidance is clear: do not drink it and do not second-guess the decision to throw it out.
The Science Behind the Danger: What Is Clostridium Botulinum?
The word "botulism" gets thrown around in food safety discussions, but relatively few people have a working understanding of what actually makes this bacterium so uniquely threatening. According to the Centers for Disease Control and Prevention, Clostridium botulinum produces a toxin that attacks the body's nerves. It is not a stomach bug in the conventional sense — it is a neurotoxin, and the mechanism by which it causes harm is categorically different from the gastrointestinal distress most people associate with food poisoning.
Botulism attacks the nervous system, causing muscle weakness, trouble breathing, paralysis, and in extreme cases, death. Botulism, a rare but serious form of food poisoning, can cause general weakness, dizziness, double vision, and trouble with speaking or swallowing. Difficulty breathing, weakness of other muscles, abdominal distension, and constipation may also be common symptoms. Symptoms can begin from six hours to two weeks after eating food that contains botulinum toxin. The delayed onset window is particularly dangerous because it means a person may not connect their deteriorating condition to something they consumed days earlier.
Why Room Temperature Is the Enemy of Cold Brew
Because room temperature isn't cold enough, the toxin Clostridium botulinum may have formed in the cold brew. This is not a theoretical risk cooked up by overcautious regulators. Cold brew concentrate, unlike hot-brewed coffee, is a low-acid liquid product that does not go through the thermal kill step that would neutralize microbial threats. The culprit was identified as ambient storage, which creates conditions that allow Clostridium botulinum to thrive, producing the toxin associated with botulism. Clostridium botulinum is an anaerobic organism, meaning it flourishes in oxygen-poor environments — sealed bags, airtight cans, and precisely the kind of packaging used for ready-to-pour cold brew concentrates.
This is why cold-chain integrity is not optional in the ready-to-drink coffee industry. It is the primary barrier between a product designed for convenience and a product capable of causing serious neurological harm. When that chain breaks — whether at the distributor level, the retail level, or somewhere in between — the margin for error disappears fast.
Understanding the FDA's Class II Classification
Not all food recalls are created equal, and the FDA's tiered classification system exists to communicate precisely that. The agency defines a Class II recall as a situation in which exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious health consequences is considered remote. In plain terms, Class II means the FDA considers a worst-case scenario unlikely but not impossible — and the distinction matters when trying to calibrate how urgently to act.
A Class II recall means that using or being exposed to the product could result in temporary or medically reversible health effects, but the probability of serious health problems is remote in this case. That is the regulatory framing, and it is genuinely reassuring in a technical sense. But it is worth being careful not to let the classification become a reason to take the recall less seriously than it deserves. Despite this classification outlining low risk of serious health effects involving the cold brew, any potential chance of getting botulism shouldn't be shrugged off. According to the CDC, botulism attacks the nerves in your body and is always considered a medical emergency. Botulism can, in severe cases, lead to breathing problems and muscle paralysis, and can even be fatal.
The Gap Between "Remote" and "Zero"
The critical distinction in the Class II language is the word "remote" — not "impossible." The FDA is not saying there is no risk. It is saying serious adverse outcomes are statistically unlikely given the nature of the exposure window and the product's distribution footprint. But botulism is the kind of illness where even a remote probability carries weight. It is not a condition that resolves on its own. Anyone experiencing symptoms should seek immediate medical attention, according to the CDC. That is the baseline standard for a toxin that, in sufficient concentration, can stop the diaphragm from functioning.
As of the FDA's recall notice, no illnesses had been reported in connection with the affected product. That is important context, but it also reflects the reality that botulism has a lag between exposure and symptom onset, and that not all cases are immediately attributed to a food source. The absence of reported illnesses is a good sign; it is not a green light to keep drinking the product.
Brooklyn Roasting Company: A Brand Under Pressure
Brooklyn Roasting Company has built a solid reputation in the specialty coffee world, operating out of one of the most coffee-saturated markets in the country. The company says it's recalling the units "out of an abundance of caution." That phrasing is standard corporate recall language, but initiating the recall voluntarily on July 2 — nearly three weeks before the FDA elevated its classification — is a meaningful data point. Companies that discover problems and disclose them proactively, rather than waiting for regulators to force the issue, tend to navigate recalls with less long-term damage to their brand credibility.
The real question the recall raises is not whether Brooklyn Roasting made a bad product, but what happened between the point of production and the point of sale. Federal officials said the recall was issued over concerns that storing the product at room temperature could create conditions that allow Clostridium botulinum bacteria to grow and produce a potentially dangerous toxin. Somewhere in the supply chain — a warehouse, a delivery truck, a retail stockroom — the temperature window was breached. Cold brew concentrate in a bag-in-a-box format is not a shelf-stable product, and it should never have left refrigerated conditions.
This Is Not the First Time Coffee Has Been Caught in a Botulism Scare
The Brooklyn Roasting recall does not exist in a vacuum. The cold brew and canned coffee industry has a documented history with botulism concerns that stretches back nearly a decade, and the pattern is instructive for anyone who drinks ready-to-consume coffee products regularly.
Death Wish Coffee, 2017
Death Wish Coffee, a brand sold with a skull and crossbones on its products, announced a recall on its cold brew coffee because it could contain a deadly toxin. The company recalled its 11-ounce Nitro Cold Brew cans after determining that its manufacturing process could lead to growth of bacteria producing botulin toxin. Mike Brown, founder of the company based in Round Lake, N.Y., said production of Nitro Cold Brew was being halted until an additional manufacturing process was implemented. The company reported no illnesses. That recall put the specialty coffee industry on notice that nitro and cold brew formats, by virtue of their chemistry and packaging, require a level of microbial vigilance that standard brewed coffee simply does not.
Snapchill LLC, 2024
The larger and more sweeping precedent came in June 2024, when the FDA became involved in a recall that dwarfed anything the industry had seen before. Snapchill LLC initiated a voluntary recall of 242 canned coffee products due to potential contamination with botulinum toxin. The recall affects products within their expiration dates, sold under various coffee roaster names across the United States, including brands such as Big Iron, Bold Bean, and Cape Cod Coffee. The FDA alerted Snapchill to the issue after discovering that the manufacturing process for these products, categorized as low-acid canned foods, was not appropriately registered with the FDA as required by regulation.
Snapchill LLC is a Wisconsin-based company that voluntarily recalled more than 250 products distributed across the country to various roasters and vendors, as well as sold to consumers online. All of the products were given a Class II risk classification by the FDA, which is "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." While no illnesses related to these products had been reported at the time, the company initiated the recall as a precautionary measure to ensure consumer safety.
The Snapchill case was particularly significant because it exposed a regulatory gap: a company producing low-acid canned foods — a category that the FDA has long recognized as high-risk for botulinum toxin formation — was doing so without properly filing its manufacturing process with the agency. The FDA raised concerns over the manufacturing practices of the canned coffee, telling the company that the agency was not notified, as per regulations, of the low-acid method of producing the canned goods. The manufacturing process posed a risk of the growth and contamination of the potentially fatal botulinum toxin.
What the Pattern Reveals About the Industry
Three separate botulism-linked coffee recalls — Death Wish in 2017, Snapchill in 2024, Brooklyn Roasting in 2026 — across a range of company sizes and operational models is not a coincidence. It reflects a structural tension at the heart of the cold brew market. The category has exploded in commercial scale over the past decade, with ready-to-drink coffee now a multi-billion-dollar segment driven largely by younger, health-conscious consumers who want their caffeine cold, convenient, and often undiluted. That growth has outpaced, in some cases, the development of robust cold-chain and food-safety infrastructure capable of supporting it.
Cold brew is brewed without heat, which means the pasteurization kill-step that protects conventional hot-brewed coffee from pathogens is not part of the base process. Products that are labeled "pasteurized" — like Brooklyn Roasting Company's concentrate — have gone through a separate thermal treatment after brewing. But pasteurization only does its job when what comes next is handled correctly: immediate refrigeration, temperature-monitored transport, and retail storage that never allows the product to return to ambient conditions. One broken link undoes all of it.
What Consumers Should Do Right Now
If you have purchased cold brew concentrate in the New York or New Jersey area — particularly any bag-in-a-box format from Brooklyn Roasting Company — there are concrete steps to follow. The recall applies to Pasteurized Cold Brew Concentrate with best-by dates from June 3 through September 3, and the affected products were distributed in New Jersey and New York between April 1 and June 20.
Consumers who have the recalled coffee should not drink it. Full stop. Do not taste-test it to see if it seems off. Botulinum toxin is odorless and colorless — there is no sensory cue that will tell you whether a product is contaminated. The only reliable action is disposal. The recall notice does not provide specific information regarding refunds or replacements of the cold brew, but consumers can contact the retailer they purchased it from and ask about that.
If you have consumed any of the cold brew, do not panic, but call your doctor right away for medical guidance. If you experience any symptoms of botulism, call 911 immediately. Symptoms to watch for include sudden muscle weakness, drooping eyelids, slurred speech, difficulty swallowing, and shortness of breath. Given that symptoms can begin from six hours to two weeks after eating food that contains botulinum toxin, the monitoring window is longer than most people expect.
The Bigger Picture: Cold Chain Accountability in the Specialty Coffee Market
The Brooklyn Roasting recall is, in microcosm, a story about the limits of quality assurance when a product leaves the producer's hands. A company can brew, pasteurize, and package a product correctly, and still end up issuing a recall because something failed downstream. That reality is uncomfortable for consumers who have placed trust in a brand name, and it points to a systemic need for greater accountability at every node in the cold-chain — not just at the factory door.
For the specialty coffee industry specifically, the past decade of rapid expansion into ready-to-drink and concentrate formats has created a category that demands the same food safety rigor applied to dairy or fresh juice. The regulatory framework exists. The science is well understood. What occasionally breaks down is execution — the unglamorous, granular work of monitoring temperatures, auditing distributors, and maintaining the kind of cold-chain discipline that keeps a product safe from the production line to the customer's refrigerator.
Until that infrastructure is uniformly strong across the supply chain, stories like this one will keep surfacing. The lesson for anyone who takes their coffee seriously is straightforward: know what you're buying, where it comes from, and how it was stored. Cold brew is not shelf-stable, and it should never be treated as though it is. When a recall notice lands, take it seriously — even when the FDA's official classification calls the risk "remote."
